Forbes: New Patent Law Would Trash Disease Cures, by Robert Nelsen and Hans Bishop
Robert Nelsen, Co-founder and Managing Director, ARCH Venture Partners, has helped to create over 30 biotech companies during the past three decades. Hans Bishop is the CEO of Juno Therapeutics, Inc., a clinical-stage company developing novel cellular… Read More »
